Concepedia

Jonathan Wise

JW

4

Publications

1K

Citations

4

H-Index

2016

Active since

Affiliations

University of Glasgow(Current)

University of Groningen

University Medical Center Groningen

University of Utah

AstraZeneca (Sweden)

Jonathan Wise is an author at University of Glasgow specializing in diabetes, medicine, and chronic kidney disease.

Top concepts

DiabetesMedicineUrologyNephrologyHealth PolicyPublic HealthRenal DiseasePharmacotherapyMetabolic SyndromeCardiovascular Disease

Publications per year

2016–2021

4

Publications

4

Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial

Hiddo J.L. Heerspink, Hans‐Henrik Parving, Dennis L. Andress et al. · The Lancet · 2019 · 589 citations · Full text

Urology, Renal Disease, Renal Events +7

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · The Lancet Diabetes & Endocrinology · 2017 · 286 citations · Full text

Metabolic Syndrome, Type 1, Diabetes Management +9

A pre-specified analysis of the Dapagliflozin and Prevention of Adverse Outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial on the incidence of abrupt declines in kidney function

Hiddo J.L. Heerspink, David Z.I. Cherney, Douwe Postmus et al. · Kidney International · 2021 · 92 citations · Full text

Efficacy and Safety of Once-Daily Insulin Degludec/Insulin Aspart versus Insulin Glargine (U100) for 52 Weeks in Insulin-Naïve Patients with Type 2 Diabetes: A Randomized Controlled Trial

Ajay Kumar, Edward Franek, Jonathan Wise et al. · PLoS ONE · 2016 · 37 citations · Full text

Rows per page

1–4 of 4